Podcasts by Aptose Biosciences Inc. (TSX: APS)
Podcast with news and updates from Aptose Biosciences (NASDAQ: APTO, TSX: APS), a science-driven biotechnology company advancing first-in-class agents to treat life-threatening cancers, such as acute myeloid leukemia (AML), high-risk myelodysplastic syndromes (MDS) and other hematologic malignancies. Based on insights into the genetic and epigenetic profiles of certain cancers and patient populations, Aptose is building a pipeline of novel oncology therapies directed at dysregulated processes and signaling pathways.
Further podcasts by Aptose Biosciences Inc.
Podcast on the topic Geldanlage
All episodes
William Rice, CEO and Greg Chow, CFO of Aptose Biosciences Molecule Expected to Return to Clinic from 2018-05-30T21:00
William Rice, CEO and Greg Chow, CFO of Aptose Biosciences Molecule Expected to Return to Clinic
Listen